AGENT FOR INDUCING CELL DEATH, AGENT FOR SUPPRESSING CELL PROLIFERATION, AND PHARMACEUTICAL COMPOSITION USED FOR TREATMENT OF DISEASE RESULTING FROM ABNORMAL CELL PROLIFERATION

It becomes possible to induce cell death of cancer cells and inhibit cell proliferation of cancer cells. A medicinal agent capable of inhibiting both of GST-p and MRPL17 is contained as an active ingredient, or a medicinal agent capable of inhibiting GST-p and a medicinal agent capable of inhibiting...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TANAKA, HIROYUKI, MINOMI, KENJIROU
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	It becomes possible to induce cell death of cancer cells and inhibit cell proliferation of cancer cells. A medicinal agent capable of inhibiting both of GST-p and MRPL17 is contained as an active ingredient, or a medicinal agent capable of inhibiting GST-p and a medicinal agent capable of inhibiting MRPL17 are contained as active ingredients. La présente invention permet d'induire la mort cellulaire de cellules cancéreuses et d'inhiber la prolifération cellulaire de cellules cancéreuses. Un agent médicinal capable d'inhiber à la fois GST-p et MRPL17 est compris en tant que principe actif, ou un agent médicinal capable d'inhiber GST-p et un agent médicinal capable d'inhiber MRPL17 sont compris en tant que principes actifs.